Market Research Report Store eClinical Solutions Market Estimated to reach 7.61

"eClinical Solutions Market Estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022)" published in June 2017. It is a professional and in-depth study. Summary Market Research Report Store announces a new report＂eClinical Solutions Market＂added to its database.The global eClinical solutions market is estimated to reach 7.61 billionby 2022, at a high CAGR of 12.4% in the forecast period (2017-2022). The growth of the global eClinical solutions market is driven by factors such as a need for improved data standardization and an increase in R&D expenditure by pharma-biotech companies with significant IT budgets for drug development. In addition, the rising number of clinical trials, especially across emerging countries in the Asia-Pacific region, offers growth opportunities for vendors of eClinical solutions. Detailed TOC Of Report @ https://www.marketresearchreportstore.com/shop/eclinical-solutions-market-by-product-cd ms-edc-ctms-ecoa-analytics-rtms-etmf-safety-delivery-mode-on-demand-on-premise-cloud- based-clinical-trial-phases-end-user-pharmabiopharma-comp-2 Ask a sample, click here [email protected] On the basis of clinical trial phases, the global eClinical solutions market is divided into phase I, phase II, phase III, and phase IV. The phase III clinical trials segment accounted for the largest share of the global eClinical solutions market in 2016. In addition, the phase III clinical trials segment is expected to grow at the highest CAGR during the forecast period. Geographically, North America commanded the largest share of the global eClinical solutions market in 2016, followed by Europe. The large market share of North America is attributed to the significant number of ongoing clinical trials in this region. A number of factors such as the increasing government grants to support clinical trials, continuous product development and launch by eClinical solution vendors, growth in the number of partnerships for new drug development, high prevalence of lifestyle diseases, and an increasing aging population are further stimulating the demand for eClinical solutions in North America. However, strict and lengthy government requirements and high cost of conducting trials are negatively affecting the growth of the market in this region. Although developed regions such as North America and Europe held large shares in the eClinical solutions market in 2016, it is the Asia-Pacific region that is poised to achieve the highest CAGR in the next five years. Factors such as the increasing outsourcing of clinical trial studies by large pharma and biopharma companies to Asia-Pacific countries, the presence of large patient population, and the low operating cost of conducting clinical trials are propelling the growth of the eClinical solutions market in this region.